Clinical Trials Browser

Phase 4 × Immunoproliferative Disorders × Brentuximab Vedotin × Clear all

Hematologic Diseases, Hodgkin Disease, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

Clinical Trials

A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma